U.S. health information • Prescription medicines require a valid prescription and licensed pharmacy • Emergency? Call 911
HomeMedicine information
Opioid combination pain medicinePrescription medicine / verification required

Hydro Watson

Hydro Watson refers to historic Watson-imprint hydrocodone/acetaminophen combination tablets. The medicine reference describes several different imprint-to-strength associations, so the catalogue name alone does not identify a single strength or tablet.

Medicine identity referenceHydrocodone bitartrate + acetaminophen (specific strength depends on tablet imprint)Immediate-release combination tablet referencesSchedule II controlled substance (United States)
Prescription and identity verification required

This is an educational information page, not a sales listing. It does not accept orders, collect payment, or verify a prescription. Use only an appropriately licensed pharmacy and a valid prescription from a qualified prescriber. Do not use an image or informal seller description to identify a tablet.

Source basis: Chapter 8 (Hydro Watson), printed pages 18–20, in the supplied Detailed Medicine Reference Guide (compiled October 2026). Medical review status: clinician verification pending.

Product description and identification

The guide describes Watson-imprint products as hydrocodone bitartrate combined with acetaminophen (paracetamol). It lists examples including Watson 853 (10mg/325mg), Watson 540 (10mg/500mg) and Watson 385 (7.5mg/325mg). These are different strengths and should not be treated as interchangeable.

Watson Pharmaceuticals became part of a corporate lineage that later included Actavis, Allergan and Teva generics. The source also notes that many Watson imprints remain in circulation and have been copied.

Clinical context described in the reference

The reference describes hydrocodone/acetaminophen combinations as used for acute pain severe enough to require an opioid when non-opioid options are inadequate, typically over short courses. The exact approved indication and strength depend on the specific authorized product label.

Imprint and strength verification

The reference gives these examples: Watson 853 = 10/325, Watson 540 = 10/500, and Watson 385 = 7.5/325. Because the catalogue entry does not specify an imprint, the exact strength cannot be confirmed from the name “Hydro Watson”.

Watson-imprint tablets have been imitated in illicit markets. Only a pharmacy-issued container and verified prescription establish a reliable source.

Important safety warnings

Opioid boxed warnings include fatal respiratory depression, addiction, abuse and misuse, neonatal opioid withdrawal and dangerous sedation with benzodiazepines or other depressants. Acetaminophen adds risk of acute liver injury, particularly with overdose, alcohol or multiple acetaminophen-containing products.

Accidental ingestion by a child can be fatal. Treat any unidentified tablet as unknown rather than relying on a visual match.

Possible side effects

Common effects include nausea, vomiting, constipation, drowsiness, dizziness, headache, dry mouth and sweating. Serious signs include slow breathing or unresponsiveness, and liver-injury signs such as abdominal pain, jaundice or dark urine.

Drug and alcohol interactions

Alcohol, benzodiazepines, sleep medicines, other opioids, carisoprodol and sedating antihistamines can deepen sedation and breathing depression. Multiple acetaminophen products can increase liver-injury risk. The guide also describes interactions involving CYP3A4, enzyme inducers, warfarin, serotonergic medicines and MAOIs.

Pregnancy, breastfeeding and other precautions

Regular use during pregnancy may cause neonatal opioid withdrawal. Both active ingredients can pass into breast milk and infant sedation has been reported. Older adults and people with lung disease or sleep apnoea require careful professional review.

Storage and handling

Keep the exact verified product in its original labelled container, locked away from children and other people. Return leftovers through a pharmacy take-back program. The guide notes that Watson imprints can be copied.

Medicine identity at a glance

Active ingredient Hydrocodone bitartrate + acetaminophen (specific strength depends on tablet imprint)
Formulation reference Immediate-release combination tablet references
Regulatory context Schedule II controlled substance (United States)
Brand / identity reference Watson imprints; Norco and generic-equivalent family references
Important safety information: Many medicines described here are controlled or can cause serious harm. Keep them away from children and unauthorized users, avoid unapproved combinations, and use only medicine supplied by a licensed pharmacy under a valid prescription.
Patient information

Hydro Watson: medicine information and safety overview

At a glance

Hydro Watson refers to historic Watson-imprint hydrocodone/acetaminophen combination tablets. The medicine reference describes several different imprint-to-strength associations, so the catalogue name alone does not identify a single strength or tablet.

This guide page summarizes the supplied medicine-reference chapter. It is not a personalized recommendation, a product-authentication service, or a substitute for the official package leaflet. The exact formulation and manufacturer's authorization should be checked for the product actually dispensed.

Further reading and source references

These links are starting points for official or patient-facing information. Always check the leaflet and label for the precise product, manufacturer and jurisdiction.

Frequently asked questions

The guide describes historic Watson-imprint hydrocodone and acetaminophen combination tablets.

The name alone does not specify a single strength. The reference lists several different Watson imprints and strengths.

Yes. The guide identifies hydrocodone combination products as Schedule II in the United States.

No. Imprints can be copied; use only medicines from an authorized pharmacy.

?